Secondary metabolites isolated from fungi of the Xylaria genus and their antibacterial properties - a review

Résumé fourni par la source

Fungi, as living organisms, offer a vast potential for synthesizing natural compounds. Many of these compounds are highly valued as nutraceuticals and pharmaceuticals due to their medicinal properties and economic significance. Fungi are known to produce a wide range of secondary metabolites with bioactive properties, including antimicrobial and antioxidant activities, which contribute significantly to human health and well-being. In an age, when microbial antibiotic resistance increases, searching for new therapies to combat bacterial infections is in demand. Due to their ubiquitous nature, fungi are often chosen as promising candidates in the search for new antimicrobial agents. Among them, the genus Xylaria stands out. Widely distributed in subtropical and temperate regions, Xylaria species occupy various ecological niches, including decaying wood, living plant tissues as endophytes, and even the guts of termites, making their isolation both challenging and intriguing. This article reviews the literature on antibacterial compounds derived from Xylaria species, with a particular focus on those with confirmed antibacterial activity and potential applications in therapeutic protocols.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.